Ling Shan

Chinese Academy Of Medical Sciences And Peking Union Medical College Beijing
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Histological type distribution and expression of nm23, VEGF, TOP2A and MUM-1 in peripheral T-cell and NK-cell lymphomas in Chinese: analysis of 313 cases.

Histological type distribution and expression of nm23, VEGF, TOP2A and MUM-1 in peripheral T-cell and NK-cell lymphomas in Chinese: analysis of 313 cases.

Journal: International journal of clinical and experimental pathology

Published: August 07, 2018

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma.

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma.

Journal: Chronic diseases and translational medicine

Published: August 30, 2017

Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis.

Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis.

Journal: Scientific reports

Published: January 18, 2017

Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.

Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 11, 2016

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.

Journal: BMC cancer

Published: June 23, 2016

Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.

Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.

Journal: Oncotarget

Published: March 19, 2016

Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma.

Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma.

Journal: Chinese medical journal

Published: August 01, 2015

BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib.

BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 23, 2015

Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma

Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 05, 2015

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Journal: PloS one

Published: February 13, 2015

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.

Journal: PloS one

Published: February 03, 2015

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 24, 2015

Showing 1-12 of 29

Last Updated: 09/26/2026